NCT06655896 - Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cutaneous Systemic Sclerosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 29, 2024

Primary Completion Date

November 30, 2028

Study Completion Date

August 30, 2032

Conditions

Scleroderma, Diffuse

Interventions

BIOLOGICAL

rapcabtagene autoleucel

single infusion of rapcabtagene autoleucel

BIOLOGICAL

rituximab

rituximab intravenous infusion (i.v.) as per protocol

Trial Locations (55)

1011

RECRUITING

Novartis Investigative Site, Lausanne

1211

RECRUITING

Novartis Investigative Site, Geneva

2010

RECRUITING

Novartis Investigative Site, Darlinghurst

8200

RECRUITING

Novartis Investigative Site, Aarhus N

13353

RECRUITING

Novartis Investigative Site, Berlin

14004

RECRUITING

Novartis Investigative Site, Córdoba

15706

RECRUITING

Novartis Investigative Site, Santiago de Compostela

16132

RECRUITING

Novartis Investigative Site, Genova

20122

RECRUITING

Novartis Investigative Site, Milan

20132

RECRUITING

Novartis Investigative Site, Milan

21034

RECRUITING

Novartis Investigative Site, Dijon

24127

RECRUITING

Novartis Investigative Site, Bergamo

25123

RECRUITING

Novartis Investigative Site, Brescia

27100

RECRUITING

Novartis Investigative Site, Pavia

28041

RECRUITING

Novartis Investigative Site, Madrid

31008

RECRUITING

Novartis Investigative Site, Pamplona

33076

ACTIVE_NOT_RECRUITING

Novartis Investigative Site, Bordeaux

33100

RECRUITING

Novartis Investigative Site, Udine

34295

RECRUITING

Novartis Investigative Site, Montpellier

35000

RECRUITING

Novartis Investigative Site, Rennes

37007

RECRUITING

Novartis Investigative Site, Salamanca

39008

RECRUITING

Novartis Investigative Site, Santander

43210

RECRUITING

James Cancer Hospital, Columbus

52242

RECRUITING

University Of Iowa, Iowa City

55131

RECRUITING

Novartis Investigative Site, Mainz

56124

RECRUITING

Novartis Investigative Site, Pisa

57105

RECRUITING

Avera Cancer, Sioux Falls

59037

RECRUITING

Novartis Investigative Site, Lille

60126

RECRUITING

Novartis Investigative Site, Ancona

60611

RECRUITING

Northwestern University, Chicago

69003

RECRUITING

Novartis Investigative Site, Lyon

84143

RECRUITING

LDS Hospital, Salt Lake City

89081

RECRUITING

Novartis Investigative Site, Ulm

94115

RECRUITING

UCSF, San Francisco

RECRUITING

UCSF, San Francisco

94806

RECRUITING

Sutter Health Network, San Pablo

97239

RECRUITING

Oregon Health Sciences University, Portland

169608

RECRUITING

Novartis Investigative Site, Singapore

407219

RECRUITING

Novartis Investigative Site, Taichung

3109601

RECRUITING

Novartis Investigative Site, Haifa

5265601

RECRUITING

Novartis Investigative Site, Ramat Gan

6423906

RECRUITING

Novartis Investigative Site, Tel Aviv

48109 5271

RECRUITING

Michigan Med University of Michigan, Ann Arbor

04103

RECRUITING

Novartis Investigative Site, Leipzig

07740

RECRUITING

Novartis Investigative Site, Jena

06129

RECRUITING

Novartis Investigative Site, Perugia

00168

RECRUITING

Novartis Investigative Site, Roma

060 8648

RECRUITING

Novartis Investigative Site, Sapporo

920 8641

RECRUITING

Novartis Investigative Site, Kanazawa

980 8574

RECRUITING

Novartis Investigative Site, Sendai

565 0871

RECRUITING

Novartis Investigative Site, Suita

606 8507

RECRUITING

Novartis Investigative Site, Kyoto

3584 CX

RECRUITING

Novartis Investigative Site, Utrecht

08035

RECRUITING

Novartis Investigative Site, Barcelona

08041

RECRUITING

Novartis Investigative Site, Barcelona